Quantum Health executive wins Columbus CEO Volunteer of the Year award
Sandy Freer, Quantum Health s vice president of business partner relations, named Volunteer of the Year by Columbus CEO Magazine
News provided by
Share this article
DUBLIN, Ohio, March 1, 2021 /PRNewswire/
Quantum Health, the category leader in consumer healthcare navigation and care coordination, announced today that Sandy Freer, the company s vice president of business partner relations, has been named Volunteer of the Year by Columbus CEO Magazine s 2021 Healthcare Achievement Awards.
Based on a review of nominations by a panel of distinguished judges, the Volunteer of the Year award recognizes individuals who have made a positive impact in the Columbus and Central Ohio community by donating time, expertise or money to support local healthcare organizations, patients and the community. As chair of Quantum Health s Quantum Cares Committee, Freer guides the company s philanthropic efforts, supporting
Vacuna covid: ¿Qué hacer si sospechas que te pusieron una falsa?
elmanana.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elmanana.com.mx Daily Mail and Mail on Sunday newspapers.
Roundtrip expands its footprint in the state of Ohio
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Press release content from Newswire. The AP news staff was not involved in its creation.
Stemedix and the University of South Florida Join Forces
February 8, 2021 GMT
ST. PETERSBURG, Fla. - February 8, 2021 - ( Newswire.com )
Stemedix, Inc. is excited to announce its research collaboration agreement with the University of South Florida. This partnership will facilitate advancements in regenerative medicine offerings while helping provide a more precise and personalized approach to existing and future treatment options.
Stemedix, Inc. and the University of South Florida will partner together in an effort to advance the validity of stem cell treatments and overall patient outcomes. Further, this research will broaden the understanding of the full ability of current umbilical cord tissue products in the market and how they scientifically improve cell activity in the regenerative and healing process.